Literature DB >> 2114443

Differential regulation of IL-1 production in human monocytes by IFN-gamma and IL-4.

R P Donnelly1, M J Fenton, D S Finbloom, T L Gerrard.   

Abstract

We have demonstrated that IL-4 markedly inhibits IL-1 production by highly purified normal human monocytes. When added to monocyte cultures, IL-4 suppressed LPS-induced IL-1 production in a time- and dose-dependent manner. Concentrations of IL-4 as low as 100 pg/ml reduced IL-1 production by approximately 50%, and doses of 1 ng/ml or higher suppressed IL-1 production by more than 90%. Maximal inhibition required that IL-4 be added before or simultaneous with LPS. Northern dot blot analyses revealed that IL-4 not only dramatically reduced the steady-state IL-1 beta mRNA levels in LPS-stimulated monocytes, but also those of TNF-alpha and IL-6. The inhibitory effect was not stimulus-specific because IL-4 suppressed IL-1 production induced by a variety of monocyte activation stimuli, including LPS, PMA, and Staphylococcus aureus Cowan strain. Monocytes expressed a relatively small number of high affinity IL-4R (approximately 150/cell; Ka = 3.15 +/- 1.13 x 10(10) M-1) indicating that relatively few receptors are necessary to generate the inhibitory effect. IL-4 enhanced monocyte MHC class II Ag (HLA-DR) expression in a manner similar to that of IFN-gamma. However, although both IFN-gamma and IL-4 up-regulated HLA-DR expression, they exhibited opposite effects on IL-1 production: IFN-gamma significantly enhanced monocyte IL-1 production induced by submaximal concentrations of LPS; whereas, IL-4 suppressed IL-1 production. Moreover, IL-4 largely neutralized the potentiating effect of IFN-gamma suggesting that IL-4 may be an effective antagonist of certain IFN-gamma-induced effects. Together these findings demonstrate that the relative levels of IFN-gamma and IL-4 may profoundly influence the state of monocyte activation by differentially regulating the expression of IL-1.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2114443

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  27 in total

Review 1.  Foreign body reaction to biomaterials.

Authors:  James M Anderson; Analiz Rodriguez; David T Chang
Journal:  Semin Immunol       Date:  2007-12-26       Impact factor: 11.130

Review 2.  Inflammatory and immune pathways in the pathogenesis of periodontal disease.

Authors:  Ali Cekici; Alpdogan Kantarci; Hatice Hasturk; Thomas E Van Dyke
Journal:  Periodontol 2000       Date:  2014-02       Impact factor: 7.589

3.  Interleukin-4 induces the synthesis and secretion of MCP-1/JE by human endothelial cells.

Authors:  B J Rollins; J S Pober
Journal:  Am J Pathol       Date:  1991-06       Impact factor: 4.307

4.  Differential regulation of macrophage interleukin-1 (IL-1), IL-12, and CD80-CD86 by two bacterial toxins.

Authors:  D L Foss; M J Zilliox; M P Murtaugh
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

5.  Anti-inflammatory activity of nanocrystalline silver-derived solutions in porcine contact dermatitis.

Authors:  Patricia L Nadworny; Jianfei Wang; Edward E Tredget; Robert E Burrell
Journal:  J Inflamm (Lond)       Date:  2010-02-19       Impact factor: 4.981

6.  Elevated monocyte interleukin-6 (IL-6) production in immunosppressed trauma patients. II. Downregulation by IL-4.

Authors:  G Szabo; K Kodys; C L Miller-Graziano
Journal:  J Clin Immunol       Date:  1991-11       Impact factor: 8.317

7.  Coordinated antiinflammatory effects of interleukin 4: interleukin 4 suppresses interleukin 1 production but up-regulates gene expression and synthesis of interleukin 1 receptor antagonist.

Authors:  E Vannier; L C Miller; C A Dinarello
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

8.  Growth factors controlling interleukin-4 action on hematopoietic progenitors.

Authors:  A Ferrajoli; T F Zipf; M Talpaz; E A Felix; Z Estrov
Journal:  Ann Hematol       Date:  1993-12       Impact factor: 3.673

9.  Interleukin-4 suppression of monocyte tumour necrosis factor-alpha production. Dependence on protein synthesis but not on cyclic AMP production.

Authors:  P H Hart; C A Jones; J J Finlay-Jones
Journal:  Immunology       Date:  1992-08       Impact factor: 7.397

10.  Absence of exogenous interleukin-4-induced apoptosis of gingival macrophages may contribute to chronic inflammation in periodontal diseases.

Authors:  M Yamamoto; K Kawabata; K Fujihashi; J R McGhee; T E Van Dyke; T V Bamberg; T Hiroi; H Kiyono
Journal:  Am J Pathol       Date:  1996-01       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.